M&A Deal Summary |
|
|---|---|
| Date | 2022-01-01 |
| Target | Unison Infrastructure |
| Sector | Infrastructure |
| Buyer(s) | Ardian |
| Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1996 |
| PE ASSETS | 127.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
Ardian is a mega-sized diversified investment group focused on opportunities worldwide. Ardian invests across and manages funds focused on small and mid-sized buyouts, growth capital financings, mezzanine, infrastructure, real estate, and co-investment opportunities. Ardian's small-buyouts group targets controlling interests in French, German, and Italian businesses valued up to €100 million. It's mid-sized buyout group seeks businesses valued up €1.5 billion and does not have any geographic limitations. The Infrastructure team looks for European opportunities and can commit up to €1 billion per transaction. The Mezzanine group supports junior capital commitments of €5 to €80 million. In addition to direct investing, Ardian also manages various private equity fund-of-funds. Ardian was founded in 1996 and is based in Paris.
| DEAL STATS | # |
|---|---|
| Overall | 421 of 464 |
| Sector: Infrastructure M&A | 10 of 12 |
| Type: Buyout (LBO, MBO, MBI) M&A Deals | 113 of 123 |
| State: Massachusetts M&A | 1 of 1 |
| Country: United States M&A | 60 of 70 |
| Year: 2022 M&A | 2 of 8 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-01-01 |
Norstella
Yardley, Pennsylvania, United States Norstella is a global pharma intelligence solutions provider. Norstella helps life sciences clients navigate complexities at each step of the drug development life cycle, from pipeline to patient. Norstella was founded in 1994 and is based in Yardley, Pennsylvania. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-01-17 |
Biofarma
Mereto di Tomba, Italy Biofarma is involved in the development, manufacturing, and packaging of food supplements, medical devices, probiotic-based products, and cosmetics. The Group is the result of a path of aggregation of 6 complementary nutraceuticals companies (Nutrilinea, Pharcoterm, Apharm, Claire, Biofarma, and the ‘Health Science’ division of Giellepi). It offers clients an integrated offer, from research and development, to manufacturing and packaging of finished dosage form products, including regulatory support. Biofarma was founded in 1987 and is based in Mereto di Tomba, Italy. |
Buy | - |